安旭生物股价涨5.03%，广发基金旗下1只基金位居十大流通股东，持有356.45万股浮盈赚取730.73万元

Group 1 - Anxu Bio's stock increased by 5.03%, reaching 42.80 CNY per share, with a trading volume of 31.98 million CNY and a turnover rate of 0.61%, resulting in a total market capitalization of 5.439 billion CNY [1] - Anxu Bio, established on July 4, 2008, and listed on November 18, 2021, specializes in the research, production, and sales of POCT reagents and instruments, with 100% of its main business revenue coming from rapid diagnostic reagents [1] Group 2 - Among Anxu Bio's top ten circulating shareholders, GF Fund's Guangfa Value Core Mixed A (010377) increased its holdings by 549,800 shares in the third quarter, totaling 3.5645 million shares, which represents 2.8% of the circulating shares [2] - Guangfa Value Core Mixed A (010377) was established on January 22, 2021, with a current scale of 4.09 billion CNY, achieving a year-to-date return of 62.87% and ranking 441 out of 8147 in its category [2]